Background: Aminopeptidase B (Ap-B; EC 3.4.11.6) catalyzes the cleavage of basic residues at the N-terminus of peptides and processes glucagon into miniglucagon. The enzyme exhibits, in vitro, a residual ability to hydrolyze leukotriene A 4 into the pro-inflammatory lipid mediator leukotriene B 4 . The potential bi-functional nature of Ap-B is supported by close structural relationships with LTA 4 hydrolase (LTA 4 H ; EC 3.3.2.6). A structure-function analysis is necessary for the detailed understanding of the enzymatic mechanisms of Ap-B and to design inhibitors, which could be used to determine the complete in vivo functions of the enzyme.
Background
Aminopeptidase B (Ap-B; EC 3.4.11.6) activity was originally defined as an exopeptidase able to remove basic amino acid residues from the NH 2 -terminus of peptide substrates [1] . Such activity led to the hypothesis that the enzyme participates in the final steps of precursor processing, namely of neuropeptide and hormone precursors [2] [3] [4] . In most cases, proteolytic activation of peptide precursors occurs at arginine and lysine residues and involves the sequential action of an endoprotease and an exopeptidase [3] . Research efforts had focused primarily on endopeptidases cleaving at the COOH-terminus of basic amino acid doublets and on the subsequent participation of a carboxypeptidase E or H (EC 3.4.17.10; reviewed in [5, 6] ).
However, several endoproteases have been shown to produce cleavage of basic amino acid doublets on their NH 2 -terminal side [7] [8] [9] [10] . Moreover, NH 2 -terminally extended form of various peptides, bearing an extra Arg or Lys residue resulting from proteolytic processing of their corresponding precursors, have been described [11] [12] [13] [14] . Several recent studies have demonstrated that Ap-B activity occurs in combination with different proteases, such as NRD convertase [15] , Cathepsin L [16] and aminopeptidase A [17] . Although clarification of the physiological relevance of Ap-B and identification of all of its in vivo substrates is not complete, some of these substrates were recently identified. Indeed, Ap-B processes glucagon into miniglucagon in the α-cells of the islets of Langerhans [15] and could also process angiotensin peptides in rat cardiac fibroblastic cells [17] and enkephalins in various tissues [16] . The enzymatic properties of Ap-B and its expression pattern [4, [18] [19] [20] [21] [22] lead to the hypothesis that this enzyme could be involved in inflammatory processes [23] , development of tumours [24] and Type II diabetes [15] .
The biochemical characterization of the purified enzyme isolated from rat testis yielded important information. Ap-B is a monomeric 72 kDa Zn 2+ -dependent exopeptidase, which selectively removes Arg or Lys residues from the NH 2 -terminus of several peptide substrates [4] . In addition to its exopeptidase activity, Ap-B exhibits a residual capacity to hydrolyze leukotriene A 4 (LTA 4 ) into the pro-inflammatory lipid mediator leukotriene B 4 (LTB 4 ), in vitro [18] . The bi-functional nature of Ap-B is supported by a close phylogenetic relationship with LTA 4 hydrolase (LTA 4 H; EC 3.3.2.6; [18] ), which hydrolyzes LTA 4 into LTB 4 , in vivo, and exhibits an aminopeptidase activity, in vitro [25] . Both enzymes belong to the M1 family of metallopeptidases (consensus Zn 2+ -binding site HEXXHX 18 E; [18, 21, 25, 26] ).
The high-resolution crystal structure of LTA 4 H in complex with inhibitors (i.e. bestatin) was recently described [27, 28] . This was the first 3D structure determined in the M1 family of metalloexopeptidases to which Ap-B also belongs. Various attempts to crystallize Ap-B have failed due to the low solubility of the enzyme. However, the phylogenetic relationship between LTA 4 H and Ap-B offered the opportunity to model the Ap-B structure using LTA 4 H as a template in order to acquire structural data which will be essential to understand the enzymatic mechanisms, the structure of potential physiological substrates and to design potent inhibitors of Ap-B.
In this paper, we describe the production and purification of the rat Ap-B (rAp-B) in E. coli, the characterization of the recombinant protein and its catalytic properties. Eighteen different mutants were generated by site-directed mutagenesis to confirm the functional roles of conserved amino acids belonging to the M1 consensus motif [H 325 EXXHX 18 E 348 ], which constitutes the Zn 2+ -binding site. As a step toward the determination of the Ap-B catalytic mechanisms and the structural requirements for the control of substrates specificity, a complete alignment of 500 sequences of the M1 family was performed to point out conserved residues and evolutionary divergences. A part of this alignment was used for the construction of a 3D model of the whole 650 amino acid-long rAp-B based on the crystal structure of human LTA 4 H [27] in complex with Zinc ion and bestatin.
The structural relevance of some previously in silico detected consensus sites, such as RNP1 binding motif and Armadillo domain involved in protein-protein interactions is also discussed. Lastly, structural surface differences between Ap-B and LTA 4 H were examined and the results lead to the hypothesis that Ap-B exhibits numerous protein-protein interaction properties according to its putative physiological functions.
Results

Expression and purification of the E. coli recombinant rat Ap-B protein
A 1965 bp-long DNA fragment containing the rat Ap-B CDS was cloned into the pIVEX2.4 expression vector ( Fig.  1-A) . Then, the recombinant rat Ap-B protein (rAp-B) was produced with this T7 promoter-driven plasmid in a BLi5 E. coli strain. The translated product comprises a histidine tag (His-tag) at the NH 2 -terminus followed by a factor Xa restriction protease cleavage site and the rAp-B sequence, providing a 673 amino acid protein (His-rAp-B; Fig. 1-A, -B). The difference in length due to the fused His-tag/Factor Xa site tail (673 versus 650 amino acid residues) leads to a slight difference of electrophoretic mobility, which is observed in Western blot analysis ( Fig. 1-B ). This latter also shows that His-rAp-B is properly expressed in this prokaryotic expression system.
Cloning of rAp-B as a NH 2 -polyhistidine-tailed protein allows a rapid purification procedure. Figure 1 -C shows that there is a significant loss of desired His-rAp-B during the first washing. Any attempts to increase the binding specificity of the histidine tag during this step led to a decrease of specificity during the elution steps. Gel electrophoresis of the elution fractions E1 and E2 (1.5 mL each) showed only one band with a relative molecular mass around 73 kDa ( Fig. 1-C) . Both fractions were pooled and concentrated to 1 mL in Tris-HCl 50 mM pH 7.2. The final concentration of the purified His-tag rAp-B was about 160 µg.mL -1 . Consequently, an adequate quantity of enzyme is obtained with this purification procedure since we obtained 160 µg of purified protein from 50 mL of cell culture corresponding to a purification rate of 3.2 mg.L -1 .
In order to identify potential differences in the kinetic parameters of the enzyme activity due to the purification procedures, the His-tagged rAp-B was also semi-purified using a DEAE Trisacryl Plus M ion exchange column eluted with 80 mM KCl ( Fig. 1-D) . Gel electrophoresis of Cloning of rat Ap-B coding region, expression and purification of the E. coli recombinant rat Ap-B protein [18] was cloned into the pIVEX2.4 expression vector. T7 promotor, Ribosome Binding Site (RBS), translation initiation codon (ATG), Histidine tag (His Tag), Factor Xa restriction protease cleavage site (Xa or Factor Xa), NcoI and BamHI restriction sites, stop codon (***), and transcription T7 terminator (T7 Terminator) are indicated. (B) Western blot analysis of the expression of the recombinant rAp-B in E. coli. Lane 1 contains a purified recombinant rAp-B produced in a baculovirus expression system ( [29] ). Lane 2 contains a crude protein extract from pIVEX2.4-Ap-B transformed cells. Each sample (2 µL) was diluted in 20 µL of 1× Laemli buffer to avoid buffer effects during electrophoresis. Arrows indicate immunoreactive proteins corresponding to the baculovirus produced rAp-B (rAp-B; 650 amino acid residues; [29] ) and the E. coli expressed rAp-B (His-rAp-B; 673 amino acid residues), respectively. (C) Purification using Ni-NTA column. The different protein extracts analyzed are the following: C, rAp-B purified from baculovirus expression system used as a positive control; CE, crude protein extract from pIVEX2.4-Ap-B transformed BLi5 cells (5 µL); FT, proteins released after passage through the Ni-NTA column (20 µL); W1 and W2, proteins released after the first and second washing of the Ni-NTA column, respectively (20 µL); E1 and E2, proteins collected after the first and second elution step, respectively (20 µL). (D) Purification of recombinant rat Ap-B using DEAE ion exchange column. Different fractions (43, 45, 47, 49, 51, 53) collected from the ion exchange column and containing rAp-B activity were analysed (20 µL per fraction). the elution fractions containing Ap-B activity (5 mL each) showed several bands with a relative molecular mass between 35 to 115 kDa ( Fig. 1-D) . Fractions 43 to 47, which contain 4 main detectable bands on the silver stained SDS-PAGE were pooled (25 mL; Fig. 1-D) and concentrated to 5 mL in Tris-HCl 50 mM pH 7.2. The final concentration of the semi-purified proteins was ~40 µg.mL -1 versus 80 µg.mL -1 for fractions 48 to 53. Within the limits of a visual quantification, this analysis shows that the amounts of His-tagged rAp-B corresponds to about 30% of the total proteins leading to an estimated purification rate of about 1 mg.L -1 . Note that subsequent exclusion chromatography steps do not allow the separation of the contaminant proteins despite their molecular mass differences (data not shown).
A Western blot analysis completes the identification of the proteins resulting from these purification procedures ( Fig.  1 -C, -D, lower panels) and shows that no degradation products were generated. (Table 1) .
Characterization of the purified His-tagged rat
The enzymatic activity of His-rAp-B is probably higher than estimated above. Indeed, a decrease of activity due to the higher purification of the enzyme was previously described [4, 29] . Meanwhile, this purification step is required to calculate the kinetic constant such as kcat and consequently kcat/Km. Equivalent measurements using the DEAE semi-purified His-rAp-B show that enzyme activity is similar to that of Ni-NTA (Table 1) . Consequently, the semi-purified enzyme can also be used in activity assays. The comparison of kinetic values between baculovirus recombinant Ap-B [29] , rat testes enzyme [4] and E. coli recombinant protein shows that this latter constitutes a reliable tool to study the enzymatic mechanism of Ap-B, avoiding long procedures of purification ( Table  1) .
Addition of 0.2 M NaCl with either the purified rat testis Ap-B protein or the recombinant enzyme expressed in baculovirus system, results in a 3-time increase in activity [4, 29] . Consequently, the effect of NaCl was studied by assaying bacterial recombinant His-rAp-B activity in the presence of different concentrations of NaCl ranging from 0 to 2 M in 0.1 M borate buffer pH 7.4 (Fig. 2) . A similar increase of activity (about 3 fold) is observed in the range 75-400 mM NaCl with a maximum increase at 200 mM, followed by a strong inhibition.
The inhibitor profile of His-rAp-B was studied using the LArg-β-NA as substrate. As shown in Table 2 , the recombinant enzyme shows metallopeptidase properties with an inhibition of its activity with EDTA and O-phenanthroline in the milli-and micromolar concentrations, respectively. The rAp-B activity is not affected by PMSF, a serine protease inhibitor. As expected, aminopeptidase inhibitors such as bestatine (Ki = 50 nM versus 100 nM for Ap-B purified from insect cells) or arphamenine A and B (Ki = 20 nM versus 40 nM for Ap-B purified from insect cells) work in micromolar concentrations. Therefore, the recombinant enzyme exhibits the similar enzymatic properties to the testis protein.
Site-directed mutagenesis of the HEXXHX 18 E rAp-B motif
In order to probe the functional roles of several amino acids previously identified in other members of the M1 family (For review, see in [30] ), an investigation of the conserved HEXXHX 18 E motif was conducted by sitedirected mutagenesis (Table 3) . Mutants were expressed in showed that these proteins are translated from a duplicated gene encoding in tandem two similar aminopeptidases of the M1 family. The COOH-terminal domains encompassing the second aminopeptidase module of these 3 proteins were deleted from the alignment. Subsequent alignments of these domains with the consensus signature exhibited identical conserved amino acid residues (data not shown).
On the other hand, analysis of the shortest sequences revealed interesting data. Indeed, these proteins display only one of both consensus motifs of the M1 family, the Zn 2+ -binding site HEXXHX 18 E. The second consensus motif GXMEN that is classically located about 22 to 38 amino acids upstream the Zn 2+ -binding motif is missing. The glutamate alone seems to be conserved (Fig. 3 ). (Fig. 3) . The 382 remaining sequences, including Ap-B and LTA 4 H proteins, exhibit both consensus motifs of the M1 family and thus constitute a third sub-group in the latter. The multiple alignment of these 382 sequences, varying in length from 611 (leukotriene A 4 hydrolases) to 1025 (Thyrotropin-Releasing Hormone degrading enzymes) amino acids, permitted the identification of a prominent conserved region of approximately 460 residues (including gaps) containing the GXMEN motif and the Zn 2+ -binding site (HEXXHX 18 E; Fig. 4 ). This region overlaps only 316 amino acids residues in the Ap-B sequences (from Thr 168 to Pro 389 ; Fig. 4 ). This alignment reveals 61 highly conserved positions. Their conservation among several divergent prokaryote and eukaryote peptidases points their potential importance in maintaining the structural integrity of the proteins or in directly interacting with the substrates. (Fig 5-D) .
Effect of NaCl concentration on His-rAp-B enzymatic activity
The distances between the Zn 2+ ion and His 325 , His 328 and Glu 348 are 2.14 Å, 2.1 Å and 1.98 Å, respectively. A more precise definition of the structure of the catalytic domain could be done thanks to the contribution of sequences alignments. Indeed, multiple alignments highlight a 316 conserved amino acids region that lead to the hypothesis of a functional role in the exopeptidase activity of this entire region. In this case, the catalytic domain of LTA 4 H and Ap-B proteins extend into the NH 2 -terminus structural domain previously described ( [27] ; residues 168-489 for Ap-B) adopting a horseshoe shape (Fig. 5-B) . As expected, due to the high percentage of similarity between both proteins in this region, the hydrophobic cavity constituting the putative substrate-binding pocket is conserved (data not shown). 
The number of mutants analysed, the mutated codon and its corresponding amino acid, as well as the percentages of enzyme activity are indicated. The position in the rat Ap-B sequence of the targeted amino acid is numbered. The percentage of activity was determined using L-Arg β-NA as substrate. Activity assays were performed in triplicate with enzymes collected from both purification methods.
The COOH-terminal domain is formed of α-helices arranged into two layers (Fig. 5-A and 5B). The inner layer contains 5 parallel α-helices. Four anti-parallel helices, with perpendicular loops containing short helical segments on top, compose the outer layer. This coil of helices, also found in LTA 4 H structure, looks like Armadillo repeats or HEAT (Hungtington-Elongation-A-subunit-TOR; for review [32] ) motif that are suited for proteinprotein interactions [33] [34] [35] . The super-helical domain of the LTA 4 H primary structure starts from residue 463 and from position 496 for Ap-B (Fig. 5-A, -B; Fig. 6 ) and it ends with the proteins.
Structural Analysis
A detailed comparison of both structures highlights differences between Ap-B structural model and the LTA 4 H protein structure. The overall percentages of the different secondary structures differ (Ap-B: α-helix, 42%; β-sheet, 14%; loops, 44% versus LTA 4 H: α-helix, 46%; β-sheet, 23%; loops, 31%). In a model deleted from the first 30 NH 2 -terminal residues that are non homologous to LTA 4 H due to the difference in length between both proteins, these percentages can be estimated for Ap-B to: α-helix, 44%; β-sheet, 15%; loops, 41%. As shown in figure  6 , this difference in the percentage of β-sheet is mainly due to the presence of gaps in the alignment and to the weak similarity between both proteins in the NH 2 -terminal region (residues 1-133 in Ap-B sequence). Further refinement of the structure could probably slightly modify the loop/β relative percentage but the main features described below would be maintained.
The remaining part of the secondary structural alignment exhibits a high homology (Fig 6) . A very small parallel two-stranded β-sheet of three amino acids (LTA 4 (Fig. 6 ). This helical structure carries the first part of the Zn 2+ -binding motif(HEXXH). In both structures, a large α-helix (LTA 4 Comparisons of the primary and secondary structures of rat Ap-B and human LTA 4 H Figure 6 Comparisons of the primary and secondary structures of rat Ap-B and human LTA 4 H. Primary structure alignments of rat Ap-B (RnAp-B) and human LTA 4 H (HsLTA4H) are compared to secondary structures deduced from the Ap-B model (upper line) and from the LTA 4 H crystal structure (lower line; PDB accession number:1HS6; [27] ) using Procheck software. Residue accessibility computed using the Procheck software are indicated by a color code (see below). Five hydrophobic patches detected in each protein using the Quilt method are also shown in the primary structure of each enzyme. The color code (from larger to smaller patch; see also results section and Figure 8 ) is the following: red, green, magenta, cyan and yellow, respectively. Dashes typify gaps. Symbols used in the secondary structure schemes are indicated at the bottom of the figure. takes the primary structure back to the first strand to form the second strand and the small β-sheet. It should be noted that the small parallel two-stranded β-sheet of three amino acids found in Ap-B and LTA 4 H is also conserved in F3 and ePepN structures (data not shown). This small β-sheet structure might be important because it seems to link and to maintain, without too much rigidity considering its size, two important secondary structures containing conserved residues implicated in catalysis and Zn 2+ binding.
As described in the LTA 4 H structure [27] , a SH3 like motif located in a loop (P-XX-P motif; position 449-462) is also found in the Ap-B model (position 485-499; Fig. 5-C, Fig.  6 ). However, the Ap-B structural model also exhibits a second proline-rich loop in position 47-57 ( Fig. 5-C, Fig. 6 ). These motifs composed of fairly accessible residues (Fig 6) could constitute putative protein interaction domains.
Analysis of the Ap-B primary structure revealed the presence of a highly conserved RNA binding RNP1 motif (K 416 GYCFVSY 423 ; Fig. 6 ; RiboNucleoProtein 1; [37] ) usually encountered in eukaryotic hnRNP and snRNP. The whole RNP motif is, in general, composed of two motifs (RNP2, 6 amino acids; RNP1, 8 amino acids) separated by about 30 amino acid residues.
The Ap-B RNP1 motif (K 416 GYCFVSY 423 ) is found in a α-helix upstream the proline-rich loop (position 485-499). RNP1 sequence is masked by this loop and a swinging of this latter structure could render the putative RNA-binding site accessible to its substrate (Fig 5-C; Fig 6) . The Tyr 413 residue (proton donor) also belongs to this α-helix. No RNP2 consensus sequence is found in the Ap-B primary structure.
In order to perform a more precise comparison between the Ap-B model and LTA 4 H, the electrostatic potentials of the molecular surfaces of both proteins were computed. Figure 7 represents electrostatic potential map displayed on the molecular surface of LTA 4 H (PDB accession number, 1HS6; left column) compared to the Ap-B model (rAp-B; right column). Four different orientations with their corresponding 3D ribbon structure are represented showing the 4 different sides of both proteins. The potential scale ranges from -7 kT/e to 7 kT/e (from red to blue). The electrostatic potential distribution between both enzymes is significantly different. rAp-B shows a higher negative potential (Fig 7, Orientation 1, 2 and 3 ), especially in the catalytic domain. Altogether, the α-helix and the β-sheet domains of Ap-B seem to exhibit a general negative and neutral/positive potentials, respectively. Conversely, the α-helix and the β-sheet domains of LTA 4 H exhibit a general neutral/positive and negative potentials, respectively. Interestingly, orientation 1 in Figure 7 shows, figure 6 and 8. Seven other patches, larger than 300 Å 2 (344.229 to 517.249 Å 2 , 9 to 20 residues), were also detected. As for LTA 4 H, several of these patches seem to be associated ( Fig. 6 and 8) . The association of patch 1 (1000.070 Å 2 , 30 residues, red colour in Fig. 6 and 8 ) and patch 5 (517.249 Å 2 , 11 residues, yellow colour in Fig. 6 and 8 ) constitutes a hydrophobic surface of about 1500 Å 2 . If one discards the first largest patch located in an indel region and not yet refined, the second patch is located in the β-sheet domain of the Ap-B structure where the second proline-rich loop (position 47-57; Fig. 5-C) is also found. The three others clusters are situated in α-helical domains.
Discussion
In this study, we first cloned rat Ap-B CDS into an E. coli expression vector. The recombinant rAp-B was produced with a NH 2 -terminal histidine tag and was characterized.
The results showed that the expressed protein exhibits the same biochemical properties as its rat counterpart, in terms of its immunoreactivity, kinetic parameters, substrate specificity, NaCl dependence and inhibitor sensitiv- ity. Therefore, this recombinant enzyme was perfectly usable for enzymatic studies.
In order to confirm the functional role of the conserved HEXXHX 18 E motif previously studied in several other enzymes of the M1 family (For review, see [30] ), an investigation was conducted by site-directed mutagenesis. As expected, mutagenesis of any of the three zinc ligands of the H 325 EXXH 329 X 18 E 348 motif in rAp-B sequence or of the critical general base of the peptidase reaction E 326 leads to a complete lack of aminopeptidase activity.
In parallel, multiple alignments for the M1 family of aminopeptidases were performed to study the conservation of the residues involved in the exopeptidase activity, these residues constituting eventual targets for further sitedirected mutagenesis studies. Our results clearly demonstrate that 3 sub-groups or sub-families constitute the current M1 aminopeptidase family. The main difference between these sub-groups is the presence or the partial loss of a GXMEN motif upstream the Zn 2+ -binding site. The first sub-family is restricted to Actinobacteria (loss of Gly, Met, Asn and conservation of Glu). A second subfamily (lack of Gly, Glu, Asn and conservation of Met) is composed of only one member expressed in Vertebrates (Ap-O; [31] ). Interestingly, numerous site-directed mutagenesis studies of the GXMEN motif among the M1 family(Aminopeptidase A, Ap-A, [38] ; Aminopeptidase N, Ap-N, [39] ; Thyrotropine Releasing Hormone Degrading Enzyme, TRH-DE, [40] ; LTA 4 H, [41] ) suggested that the glutamate and asparagine residues are implicated in the transition state stabilisation. Moreover, these residues, that might interact with the NH 2 -terminus of substrates, are also suspected to be responsible for the aminopeptidase specificity. The Gly residue (an exception is found for TRH-DE, Ala versus Gly) seemed crucial for the activity because its replacement with bigger or polar residues abolishes the activity [40] . Lastly, the mutation of the methionine affects both Km and Vm, but no precise role of this residue was proposed [42] . Meanwhile, Ito and collaborators [43] dase with specificity for Arg and Asn residues [31] . Further investigation on evolutionary relationships between these proteins and especially on their enzymatic characterization constitute a major goal to grasp the physiological role of these aminopeptidases implicated in fundamental processes of cell metabolism.
In order to investigate the catalytic mechanism of Ap-B, we used molecular modelling. In the present work, we generate a molecular model of the whole rat Ap-B structure based on the crystal structure of the human LTA 4 H [27] . The crystal structures of the Tricorn interacting factor F3 (F3; [44] ) and of the aminopeptidase N from E. coli (ePepN; [43, 45] ), two other members of the M1 family that exhibit less than 25 % of identity with LTA 4 H and Ap-B, were considered to be not closely related to Ap-B. Moreover, 4 structural domains exist in F3 [44] and ePepN [43, 45] . Interestingly, this fourth domain is inserted just upstream the conserved amino acid region highlighted in the multiple alignment (Fig. 4, position 490 ). The Ap-B model is quite comparable to the LTA 4 H structure particularly at the level of their catalytic domains. Examination, in both structures, of the distances between Zn 2+ ion and the chelating residues His 325 , His 328 and Glu 348 , as well as the shape and size of the substrate-binding pocket shows a perfect homology.
The Ap-B structural model was also used to examine in silico predicted domains. The Ap-B primary structure contains a high consensual RNA binding RNP1 motif [37] . The whole consensus RNP motif is composed of two motifs RNP2 and RNP1, both are highly conserved and are usually found in simple or multiple copies (1 to 4). RNP domain folds into a compact and hydrophobic αβ structure (βαβ topology, a four anti-parallel β-sheet framed by 2 α-helices perpendicular one to another). RNP1 and RNP2 are found in the two central (underlined) strands, β4-β1-β3-β2. In Ap-B, the absence of RNP2 motif and the fact that RNP1 is not included in a β-sheet could prevent a functional role in RNA binding. Indeed, the presence of this RNP1 motif could be attributed to a vestigial persistence resulting from gene duplications and a loss of nuclear functions in the course of the evolutionary process. Conversely, the presence of a different RNP domain in Ap-B structure could lead to the hypothesis that this protein has gained new interactions via new domains and new structures. RNP1 might be functional and form a particular structure with another motif than RNP2. Indeed, the Ap-B primary structure contains putative nuclear localization sequences and some data supports the hypothesis that this exopeptidase could migrate to the nuclear compartment (unpublished results). Further studies should demonstrate whether Ap-B is also a nuclear protein. In this case, the role of this RNP1 motif will remain to be clarified.
The COOH-terminal domains of LTA 4 H and Ap-B show a structural region similar to the Armadillo repeats or to the HEAT domains. These folds are usually composed of 3 to 36 pairs of anti-parallel α-helices that together form superhelices. The α-helices are commonly 37 to 47 amino acids long in the heat domains and about 40 amino acids long in the armadillo repeats. The known proteins containing these motifs share functions in protein-protein interaction/recognition [33] [34] [35] . Although this putative domain in Ap-B and LTA 4 H exhibits shorter α-helices (maximum of 15 residues), the super helical fold present in both structures could lead to variations in the strength of interactions and/or to different interacting proteins.
In addition to the potential HEAT domain, Ap-B exhibits several other features, such as putative SH3 domains, negative electrostatic potential, large hydrophobic patches leading to the hypothesis that this enzyme might interact with different partners in different functions. These characters are generally different from those of LTA 4 H and have been highlighted by the structural model proposed. Differences in the electrostatic potential distribution between Ap-B and LTA 4 H might reflect putative (or different) protein-protein interactions. Ap-B interacts with the outer cytoplasmic membrane of cells and this interaction might occur by protein-protein interactions [4, 19] . Ap-B participates, probably with different endopeptidases, to an initial maturation process of neuropeptides and prohormones that might involve an endopeptidase/aminopeptidase complex [4, [15] [16] [17] [18] . Similar roles could be attributed to hydrophobic patches, which delineate putative interacting surface. Ap-B exhibits larger hydrophobic patches than LTA 4 H. On the other hand, the negative electrostatic potential at the level of the catalytic site might explain the difference of enzyme specificity and between their respective substrates: rather negative for LTA 4 H, rather positive for Ap-B. Indeed, a long loop found in both enzymes (Ap-B, K 395 LRVKIEPGVDPDDTY 410 ; LTA 4 H, K 364 LVVDLTDIDPDVAY 378 ; Fig. 4 ), delimits and separates the active center from the protein surface. This loop, containing a small α-helix, seems to be involved in substrate specificity as shown by site-directed mutagenesis studies (LTA 4 H, [46] ; TRH-DE, [47] ; Ap-B, [48] ) and structural data (LTA 4 H, [27] ). A detailed examination of the corresponding sequences shows that the LTA 4 H sequence is more hydrophobic than the Ap-B sequence, the latter exhibiting a high number of basic amino acids. Moreover, the distribution of acidic residues shows a significant difference in both loops. They are regularly distributed in the LTA 4 H loop structure and rather gathered up one end of the loop in Ap-B, the last aspartate residue belonging to the small α-helix pointing towards the active site.
This might explain the affinity and the positioning of the Ap-B substrate. Basic peptidic substrates might be attracted to the protein surface and to the active site by the negative electrostatic potential. Then, substrate could be guided towards the active center by the presence of hydrophobic and basic residues until stronger interactions occurred involving negatively charged aspartate. The presence of the α-helix might bring some precision and stability to the substrate binding mechanism, balancing the flexibility of the loop.
Conclusion
The structural model proposed is the first attempt for a better understanding at an atomic scale of the Ap-B protein. The Ap-B 3D model, based on the fold of LTA 4 H, yields important additional information that open the way to design new experiments. For instance, electrostatic potentials computed here, by nature, are features that can only be calculated from a 3D structure, they result from the superposition of the contribution of all the charges of the atoms in a given point. Consequently, a simple sequence analysis cannot foreshadow the electrostatic values. The results we described here illustrate clearly the necessity to go further than simply describing the main fold characteristics to detect fine surface properties of the protein. The important differences in these features compared to LTA 4 H show without ambiguity that the nature or the way the partners interact with Ap-B, the environment impact, would be different from LTA 4 H. Although the complete range of physiological functions of Ap-B remain to be discovered, previous data support the hypothesis that Ap-B is involved in a broad spectrum of relevant physiological phenomena. The specific exopeptidase activity of Ap-B participates in the final steps of neuropeptides and hormones processing (for review, see [15] [16] [17] 49] ). Besides, the enzyme has been implicated in inflammation and/or tumor growth [23, 24] . These latter roles might be due to the in vitro residual capacity of Ap-B to hydrolyze the LTA 4 into a lipid mediator of inflammation, the LTB 4 [18] . In the absence of high-resolution crystal structure, as demonstrated for aminopeptidase A [50, 51] and numerous other proteins, this model constitutes a powerful tool for investigating the importance and possible roles of conserved residues in Ap-B and M1 aminopeptidase catalytic sites and to gain new insight into their physiological functions.
Methods
Construction of the prokaryotic recombinant rAp-B expression vector
The rat Ap-B cDNA was initially cloned into the SrfIdigested pPCR-Script vector (Stratagene, La Jolla, USA) to obtain the prAp-B plasmid [29] . Both prAp-B and the pIVEX2.4 expression vector (Roche Diagnostics, Meylan, France) were digested with NcoI and BamHI restriction enzymes. The resulting Ap-B cDNA fragment was isolated, purified (QIAquick gel extraction kit, Qiagen, Hilden, Germany) and ligated (T4 DNA ligase, New England Biolabs, Hertfordshire, England) into the digested pIVEX2.4 plasmid to obtain the pIVEX2.4-Ap-B recombinant plasmid, which was checked by sequencing (Genome Express facilities, Meylan, France).
Production of rat Ap-B in E. coli
In order to produce rAp-B, we used a T7 promoter-driven system and a BLi5 E. coli strain [52] . Ten milliliters of LB medium supplemented with 20 µg/mL chloramphenicol and 100 µg/mL ampicillin were inoculated with Bli5 cells harboring the pIVEX2.4-Ap-B recombinant plasmid and incubated overnight at 37°C with agitation. The overnight culture was then diluted to 1:50 with 50 mL of fresh LB medium containing 100 µg.mL -1 ampicillin and was grown under vigorous shaking at 37°C until the OD 600 reached 0.6. Isopropyl β-D-1-thiogalactoside (IPTG; Sigma-Aldrich, Saint Quentin Fallavier, France) was added to a final concentration of 1 mM and the expression culture was grown at 37°C with agitation for 2 hours. Cells were then harvested by centrifugation at 4,000 × g for 5 min and stored at -80°C until use or processed immediately as described below for Western blotting, purification and enzymatic activity assays.
Purification of the recombinant His-tagged rat Ap-B
Purification using Ni-NTA agarose. pIVEX2.4-Ap-B transformed cell pellets from an expression culture (see above) were resuspended in 5 mL of lysis buffer (5 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl, pH 8) and sonicated, at 40 Mcycles, 3 times during 1 min at 4°C. The extract was centrifuged at 10,000 × g for 5 min at 4°C to pellet the cellular debris. The supernatant was collected and mixed with Ni-NTA agarose (v/v; Quiagen, Hilden, Germany), which was pre-equilibrated with lysis buffer. The mixture was incubated with gentle mixing for 1 H at 4°C and applied to a minicolumn for gravity flow chromatography. The column was washed 3 times with 3 to 5 mL of washing buffer (40 mM imidazole, 2 M NaCl, 20 mM TrisHcl, pH 8). Finally, the His-tagged purified protein was eluted by 4 successive elutions with a buffer composed of 100 mM imidazole, 200 mM NaCl and 20 mM Tris-HCl at pH 8. Purification using DEAE ion exchange column. The recovered supernatant (5 mL, see above) was diluted to 30 mL in 50 mM Tris-HCl pH 7.2, 1 mM β-mercaptoethanol. Then the solution was applied to a DEAE Trisacryl Plus M ion exchange column (100 mL bed volume; BioSepra, Villeneuve la Garenne, France) pre-equilibrated in 50 mM Tris-HCl pH 7.2. Proteins were eluted using a continuous gradient from 0 to 100 mM KCl. The resulting active fractions (5 mL) were concentrated and equilibrated in 50 mM Tris-HCl pH 7.2, 1 mM β-mercaptoethanol using a stirred ultrafiltration cell (Amicon, model 8050; Ultrafiltration membrane YM 30; Millipore Corporation, Bedford, MA, USA).
The determination of the protein concentrations in the different steps of the purification procedure was performed using the Bradford method. The concentration of the purified Ap-B was calculated using its molar absorbance coefficient (105.530 at 280 nm).
Western blotting
BLi5 or pIVEX2.4-Ap-B transformed cells were resuspended in PBS supplemented with 2 mg/mL lysozyme. Lysis was completed by 15 passages through a 25-gauge needle and 3 sonication steps of 1 min at 40 Mcycles at 4°C. The protein extracts were centrifuged at 4,000 × g during 5 min at 4°C. The supernatants containing the soluble intracellular proteins were retained. Aliquots of protein extracts or purified proteins were run under denaturing conditions on an 8% polyacrylamide gel (SDS-PAGE). Then, they were transferred to a nitrocellulose membrane (0.45 µm, Schleicher & Schuell, Dassel, Germany) using a semi-dry blotting apparatus (Hoefer scientific instruments, San Francisco, USA). The rat Ap-B was detected with a specific anti-Ap-B polyclonal serum [4] at a dilution of 1:2000. Antigen-antibody complexes were visualized using a goat alkaline phosphatase coupled secondary antibody (Sigma-Aldrich, Saint Quentin Fallavier, France) and an NBT-BCIP mixture (Sigma-Aldrich, Saint Quentin Fallavier, France). SDS-PAGE gels were stained with silver salts [53] to visualize the proteins.
Site-directed mutagenesis
The pIVEX2.4-Ap-B recombinant expression vector was used for site-directed mutagenesis and mutants were generated with the QuickChange ® Multi Site-Directed Mutagenesis kit according to the manufacturer specifications (Stratagene Europe, Amsterdam, Netherlands). This system allows randomizing the targeted amino acids using oligonucleotides containing degenerate codons (see below). All the primers used for mutagenesis were 5'-phosphorylated. A single oligonucleotide per site was used in each experiment. The targeted amino acids and their corresponding mutagenic primers were the following: H325, 5'-TGTGGGAGATCTCATRGATGATGACGTCG G-3' for the H325Y and H325H mutants, 5'-TGTGGGA-GATCTCGAAGATGATGACGTCGG-3' for the H325F mutant, 5'-TGTGGGAGATCTCGGCGATGATGACGTCG G-3' for the H325A mutant; E326, 5'-ACTGTGGGAGAT-STTGTGGATGATGACGTC-3' for the E326Q and E326E mutants, 5'-ACTGTGGGAGATCKCGTGGATGATGACGT C-3' for the E326A and E326E mutants, 5'-ACTGTGGGA-GATWTCGTGGATGATGACGTC-3' for the E326D and E326E mutants, 5'-ACTGTGGGAGATGTAGTGGATGATG ACGTC-3' for the E326H mutant; H329, 5'-TTCCCAAAC-CAACTATRGGAGATCTCGTGG-3' for H329Y and H329H mutants, 5'-TTCCCAAACCAACTGAAGGAGATCTCGTGG -3' for H329F mutant, 5'-TTCCCAAACCAACTGGCGGA-GATCTCGTGG-3' for H329A mutant; E348, 5'-CATGGT-GAAGCCMTCATTGAGCCAGAATTC-3' for the E348D and E348E mutants, 5'-CATGGTGAAGCCCKCATTGAGC CAGAATTC-3' for the E348A and E348E mutants, 5'-CAT-GGTGAAGCCCTSATTGAGCCAGAATTC-3' for the E348 Q and E348E mutants, 5'-CATGGTGAAGCCGTGATT-GAGCCAGAATTC-3' for the E348H mutant. Mutants such as H325H, E326E, H329H and E348E are conservative mutants. The mutagenic codon was underlined in the oligonucleotide sequence. The code for degenerate codons was: R = A, G; S = C, G; K = G, T; W = A, T; M = A, C. Generated mutants were identified by direct sequencing on both strands using the dideoxy chain-termination procedure (Genome Express facilities, Meylan, France).
Enzyme activity assays
Rat Ap-B activity was determined using the L-Arg-and LLys-β-naphthylamide (L-Arg-β-NA, L-Lys-β-NA; SigmaAldrich; Saint Quentin Fallavier, France) substrates and a specific inhibitor, arphamenine B (Sigma-Aldrich; Saint Quentin Fallavier, France) as previously described in [4] . Briefly, protein extracts were pre-incubated with or without 1 µM arphamenine B for 15 min at 37°C in assay buffer (50 mM Tris-HCl pH 7.4) prior to incubation at 37°C for 60 min in the assay buffer containing 0.2 mM LArg-β-NA. Hydrolysis was interrupted by the addition of 0.3 mL of freshly prepared color reagent (Fast Garnet GBC salt; Sigma-Aldrich; Saint Quentin Fallavier, France). The absorbance was read at 535 nm using a spectrophotometer. The percentage of rAp-B activity, which is equivalent to the percentage of inhibition, was measured by comparison with values obtained without inhibitor. Although no other peptidase activities were detectable in purified or semi-purified proteins, activity assays with wild type HisrAp-B enzyme were performed as described above.
Sequence analysis Version 2.2.10 of the BLASTP program [54] was used, with default parameters (BLOSUM62 matrix), to identify members of the M1 family of metalloexopeptidases. The Uniprot database (Release 29.0) was queried with the rat Ap-B protein sequence (accession no U61696; [18] ) and 512 hits were observed. Among these hits, 500 amino acid sequences exhibiting an E value between 0 and 1.e -8 were selected. These 500 protein sequences were aligned using CLUSTALW version 1.0; [55] . The alignment was refined manually to minimize the number of gaps. Sequences, which exhibited obvious mistranslations resulting from sequencing errors, were deleted from the alignment. The complete listing of the sequence descriptions and the initial and final multiple alignments are available upon request. The PATTERNp program [56] was used to define the consensus amino acid signatures of the M1 family.
Molecular Modelling
Homology models were constructed as described in [57, 58] . Briefly, models were constructed with Modeller package 6.2 version using the 3D structure of the leukotriene A4 hydrolase in complex with Zinc ion and bestatin as a template [27] . In the template structure, the bestatin molecule is located in a tunnel-like cavity. In the model, we do not consider the bestatin molecule for two reasons: i) further theoretical parameters are required for optimizing the whole complexed structure and ii) leaving the cavity free permits a comparison of the difference or similarities in the physico-chemical features of the tunnel in both structures.
The alignment used is described in Figures 4 and 6 . Among the 100 models constructed that mainly differ in the indel regions, the 3D model with the optimal objective function was selected ("Initial Model"). Side chains were then repositioned with Scwrl3.0 software. Zinc ion was placed in an equivalent position as observed in the crystal structure of LTA 4 H. Structure refinement was performed with energy minimization in vacuum with NAMD package using Charmm force field parameters. A 12 Å cutoff for coulombic interactions was used coupled with 8 Å switching distance. The minimization process was performed in two steps: i) all the atoms of the protein were fixed while the Zn ion was free to move then ii) all the side chains and the Zn ion were free to reorient but the backbone was maintained fixed. The minimization procedure was performed until a gradient tolerance of 10 -6 or less was reached. We did not perform any further minimisations freeing all the atoms because of the absence of a proper explicit environment and also for best maintaining the size of the bestatin pocket. The geometric quality of the structure was assessed with Procheck. The quality of the model was tested using 3D-evaluation tools available on the meta-server bioserv [59] . The model was considered to be good with Verify3D, ProsaII and Eval23D, although the average scores were lower with the two last methods.
Structural Analysis
The structural analysis of the Ap-B model was performed as described in [57, 58] . Pocket cavities in the minimized structures were explored using the CastP server.
Electrostatic potentials were computed with Delphi. The dielectric interior and exterior were respectively fixed to 4 and 80. The computation was performed with a null salt concentration. A probe radius equal to 1.4 Å was chosen. The charges and radii correspond to PARSE parameters. The potential was plotted on the surface computed with the MSMS software. A similar computation was performed on the equivalent domain of the LTA 4 H structure, corresponding to the aligned regions between the two sequences.
Hydrophobic patches on the surface were computed according to the Quilt approach. The results depend on different parameters that can be specified: atomic radii, probe radius, polar expansion and point density per atom. The computations were performed with an expansion value of 1.4 Å for the radii of polar atoms (same as the probe radius) as suggested in the original publication. The number of point density per atom was equal to 252. Statistical relevance of patches was evaluated according to the randomization process proposed by the authors. We chose 10 iterations for the assessment. 
